DUSKEY, JASON THOMAS
 Distribuzione geografica
Continente #
NA - Nord America 4.940
EU - Europa 4.133
AS - Asia 3.157
SA - Sud America 393
Continente sconosciuto - Info sul continente non disponibili 107
AF - Africa 71
OC - Oceania 9
Totale 12.810
Nazione #
US - Stati Uniti d'America 4.832
SE - Svezia 1.936
IT - Italia 1.041
SG - Singapore 985
CN - Cina 801
VN - Vietnam 355
HK - Hong Kong 354
GB - Regno Unito 350
BR - Brasile 295
BD - Bangladesh 187
DE - Germania 158
RU - Federazione Russa 139
FI - Finlandia 125
FR - Francia 106
KR - Corea 89
ID - Indonesia 66
IN - India 65
CA - Canada 61
NL - Olanda 50
AR - Argentina 39
JP - Giappone 39
TR - Turchia 39
BG - Bulgaria 35
MY - Malesia 29
UA - Ucraina 27
PK - Pakistan 24
MX - Messico 23
ZA - Sudafrica 22
ES - Italia 21
IQ - Iraq 21
PL - Polonia 19
IE - Irlanda 18
LT - Lituania 18
CH - Svizzera 15
VE - Venezuela 15
BE - Belgio 14
AE - Emirati Arabi Uniti 12
EC - Ecuador 12
PH - Filippine 12
RO - Romania 12
AT - Austria 11
TN - Tunisia 11
CO - Colombia 10
IL - Israele 9
MA - Marocco 9
TH - Thailandia 9
CR - Costa Rica 8
AU - Australia 7
DK - Danimarca 7
NP - Nepal 7
PY - Paraguay 7
TW - Taiwan 7
UZ - Uzbekistan 7
CL - Cile 6
PT - Portogallo 6
DZ - Algeria 5
ET - Etiopia 5
GR - Grecia 5
JM - Giamaica 5
SA - Arabia Saudita 5
BY - Bielorussia 4
CZ - Repubblica Ceca 4
EG - Egitto 4
QA - Qatar 4
GE - Georgia 3
GT - Guatemala 3
IR - Iran 3
KE - Kenya 3
KG - Kirghizistan 3
LY - Libia 3
PE - Perù 3
AM - Armenia 2
AN - Antille olandesi 2
AZ - Azerbaigian 2
BO - Bolivia 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
EE - Estonia 2
EU - Europa 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NZ - Nuova Zelanda 2
OM - Oman 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
CU - Cuba 1
CY - Cipro 1
GY - Guiana 1
HU - Ungheria 1
IS - Islanda 1
JO - Giordania 1
LV - Lettonia 1
Totale 12.691
Città #
Stockholm 1.778
Santa Clara 620
Singapore 620
Ashburn 583
Fairfield 365
Hong Kong 344
Chandler 286
Hefei 276
San Jose 276
Woodbridge 166
Council Bluffs 151
Seattle 149
Modena 143
Cambridge 142
Houston 142
London 133
Southend 132
Los Angeles 129
Wilmington 128
Beijing 126
Nyköping 125
New York 122
Ho Chi Minh City 112
Chicago 107
Helsinki 101
Dallas 91
Bologna 90
Seoul 86
Hanoi 85
The Dalles 65
Munich 58
Milan 57
Lauterbourg 53
Jakarta 52
Shanghai 50
San Diego 42
Reggio Emilia 41
Ann Arbor 38
Moscow 38
Rome 38
Princeton 33
Sofia 33
Buffalo 31
Falls Church 31
Frankfurt am Main 28
São Paulo 28
Salt Lake City 22
Tokyo 22
Boardman 21
Phoenix 20
Da Nang 19
Orem 19
Dearborn 18
Montreal 18
Parma 18
Atlanta 16
Jacksonville 16
Turku 16
Warsaw 16
Brooklyn 15
Johannesburg 15
Kent 15
Tampa 15
Amsterdam 14
Castrezzato 14
Dublin 14
Elk Grove Village 14
Haiphong 14
Nuremberg 14
Denver 13
Des Moines 13
Guangzhou 13
Dong Ket 12
Florence 12
Redondo Beach 12
Wuhan 12
Ankara 11
Catania 11
Izmir 11
Miano 11
Mumbai 11
Naples 11
Redwood City 11
Boston 10
Brussels 10
Düsseldorf 10
Eugene 10
Portsmouth 10
Rio de Janeiro 10
Shenzhen 10
Turin 10
Iowa City 9
Mexico City 9
Toronto 9
Baghdad 8
Chennai 8
Ninh Bình 8
Vienna 8
Bari 7
Columbus 7
Totale 9.026
Nome #
"Combo" Multi-Target Pharmacological Therapy and New Formulations to Reduce Inflammation and Improve Endogenous Remyelination in Traumatic Spinal Cord Injury 2.041
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 363
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 331
Targeting Brain Disease in MPSII: Preclinical Evaluation of IDS-Loaded PLGA Nanoparticles 324
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 322
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 313
Applications of the ROS-Responsive Thioketal Linker for the Production of Smart Nanomedicines 286
Nanomedicine against Aβ aggregation by β–sheet breaker peptide delivery: In vitro evidence 281
Investigating Novel Syntheses of a Series of Unique Hybrid PLGA-Chitosan Polymers for Potential Therapeutic Delivery Applications 278
Novel peptide-conjugated nanomedicines for brain targeting: In vivo evidence 276
Optimization of an Injectable Hydrogel Depot System for the Controlled Release of Retinal-Targeted Hybrid Nanoparticles 274
Drug delivery across the blood–brain barrier: recent advances in the use of nanocarriers 273
Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain 271
Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy 271
Microfluidic technology for the production of hybrid nanomedicines 260
Challenges of enzyme therapy: Why two players are better than one 250
Synthesis, Characterization, and In Vitro Studies of an Reactive Oxygen Species (ROS)-Responsive Methoxy Polyethylene Glycol-Thioketal-Melphalan Prodrug for Glioblastoma Treatment 246
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease 244
Polymer-lipid hybrid nanomedicines to deliver siRNA in and against glioblastoma cells 238
Tween® preserves enzyme activity and stability in PLGA nanoparticles 226
Recent Advances on Surface-Modified GBM Targeted Nanoparticles: Targeting Strategies and Surface Characterization 224
Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function 222
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model 214
Tunneling Nanotubes: A New Target for Nanomedicine? 209
Nanowired Delivery of Curcumin Attenuates Methamphetamine Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic Factor 209
Nanoparticle ligand presentation for targeting solid tumors 208
Nanoparticles as carriers for drug delivery of macromolecules across the blood-brain barrier 205
Glioblastoma Multiforme Selective Nanomedicines for Improved Anti-Cancer Treatments 203
Analysis of Molecular Parameters Determining the Antimalarial Activity of Polymer-Based Nanomimics 202
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease 201
Metabolically stabilized long-circulating PEGylated polyacridine peptide polyplexes mediate hydrodynamically stimulated gene expression in liver 197
Nerve Growth Factor Biodelivery: A Limiting Step in Moving Toward Extensive Clinical Application? 196
Development and biocompatibility assessments of poly(3-hydroxybutyrate-co-ε-caprolactone) microparticles for diclofenac sodium delivery 191
Advantages and challenges of polymer-lipid hybrid nanoparticles for the delivery of biotech drugs 190
Strategies for Improved pDNA Loading and Protection Using Cationic and Neutral LNPs with Industrial Scalability Potential Using Microfluidic Technology 189
Engineered non-toxic cationic nanocarriers with photo-triggered slow-release properties 189
An overview of current drug delivery strategies for glioblastoma treatment and barriers to progress 177
Chapter 8 - Hybrid polymeric scaffolds for brain applications: locoregional glioblastoma therapy 174
Corrigendum to “Quantitative comparison of the protein corona of nanoparticles with different matrices” [Int J Pharm X 2022 Oct 21;4: 100136] (International Journal of Pharmaceutics: X (2022) 4, (S2590156722000251), (10.1016/j.ijpx.2022.100136)) 173
Chaperonin–Dendrimer Conjugates for siRNA Delivery 163
Structure-Activity Relationship of PEGylated Polylysine Peptides as Scavenger Receptor Inhibitors for Non-Viral Gene Delivery 161
Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges 160
New concepts to fight oxidative stress: Nanosized three-dimensional supramolecular antioxidant assemblies 153
Miniaturization of gene transfection assays in 384- and 1536-well microplates 149
PH-responsive PDMS-b-PDMAEMA micelles for intracellular anticancer drug delivery 147
The uptake mechanism of PEGylated DNA polyplexes by the liver influences gene expression 144
Quantitative comparison of the protein corona of nanoparticles with different matrices 143
Nanomedicines for brain diseases: Where we are and where we are going 134
PH-Triggered Reversible Multiple Protein-Polymer Conjugation Based on Molecular Recognition 133
Stimuli-Responsive Codelivery of Oligonucleotides and Drugs by Self-Assembled Peptide Nanoparticles 127
Drug delivery systems for mitochondrial targeting 55
Totale 12.810
Categoria #
all - tutte 50.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.933


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022751 55 61 39 39 58 54 36 53 102 69 97 88
2022/2023797 94 80 56 77 79 108 24 85 98 19 41 36
2023/2024699 31 60 46 57 123 93 42 81 18 34 22 92
2024/20252.530 87 43 63 161 448 326 208 164 286 114 263 367
2025/20266.387 328 195 370 473 522 264 541 287 2.302 416 294 395
2026/2027158 158 0 0 0 0 0 0 0 0 0 0 0
Totale 12.810